Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
Was This Driver Simply Having Some good times Or Behaving Like An Ass? - 2US FDA approves Kura-Kyowa's blood cancer therapy
- 32024 Ferrari Roma With Just One Owner & 3,300 Miles For Sale At $...
- 4The most effective method to Amplify Profits from Gold Speculation: Systems and Tips
- 55 Great and High Evaluated Scene Configuration Administrations For 2024
- What you need to know about flu treatments as cases spike across the US
- Before Cheap Cars Were Common, This Fiat Changed Everyday Life for Millions
- My Dad Can't Travel Like He Used to, but Slowing Down Doesn't Mean Stopping
- In these U.S. groups, deaths now exceed births. What’s happening?
- New movies to watch this weekend: See 'They Will Kill You' in theaters, rent 'Send Help,' stream 'Pretty Lethal' on Prime Video
- Russian authorities threaten WhatsApp with total ban
- Lego's $650 Pokémon set is already sold out as demand, preorders surge
- Medicine doesn’t just have ‘conscientious objectors’ − there are ‘conscientious providers,’ too
- Dinosaur collagen used to create one-of-a-kind handbag
